UGT2B15 gene.c.253G T:Geno:Pt:Bld/Tiss:Nom:Molgen

Preferred Label : UGT2B15 gene.c.253G T:Geno:Pt:Bld/Tiss:Nom:Molgen;

LOINC status : ACTIVE;

LOINC display name : UGT2B15 gene c.253G T genotype Molgen (Bld/Tiss);

LOINC long common name : UGT2B15 gene c.253G T [Genotype] in Blood or Tissue by Molecular genetics method Nominal;

LOINC short name : UGT2B15 c.253G T Geno Bld/T;

LOINC description : The patient's genotype for the c.253G T (rs1902023) variant in the UGT2B15 gene. Patients with genotype TT, for example, reportedly have a decreased clearance of lorazepam.[PMID: 15961980][PharmGKB Variant ID: 769169595];

Détails

Origin ID

94418-1;

UMLS CUI

C5381292;

Has component
- Gene [LOINC component]
- UGT2B15 gene [LOINC component]
- UGT2B15 gene c.253G>T [LOINC component]
Has method
- Molecular genetics [LOINC method]
Has property
- Genotype [LOINC Property]
Has scale
- Nom [LOINC scale]
Has system
- Blood [LOINC System]
- Blood or Tissue [LOINC System]
- Tissue and Smears [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients